The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Open accessAbstract
Gaucher disease (GD), the most prevalent lysosomal storage disease, is caused by a deficiency of glucocerebrosidase (GCase). The identification of small molecules acting as agents for enzyme enhancement therapy is an attractive approach for treating different forms of GD. A thermal denaturation assay utilizing wild type GCase was developed to screen a library of 1,040 Food and Drug Administration-approved drugs. Ambroxol (ABX), a drug used to treat airway mucus hypersecretion and hyaline membrane disease in newborns, was identified and found to be a pH-dependent, mixed-type inhibitor of GCase. Its inhibitory activity was maximal at neutral pH, found in the endoplasmic reticulum, and undetectable at the acidic pH of lysosomes. The pH dependence of ABX to bind and stabilize the enzyme was confirmed by monitoring the rate of hydrogen/deuterium exchange at increasing guanidine hydrochloride concentrations. ABX treatment significantly increased N370S and F213I mutant GCase activity and protein levels in GD fibroblasts. These increases were primarily confined to the lysosome-enriched fraction of treated cells, a finding confirmed by confocal immunofluorescence microscopy. Additionally, enhancement of GCase activity and a reduction in glucosylceramide storage was verified in ABX-treated GD lymphoblasts (N370S/N370S). Hydrogen/deuterium exchange mass spectrometry revealed that upon binding of ABX, amino acid segments 243-249, 310-312, and 386-400 near the active site of GCase are stabilized. Consistent with its mixed-type inhibition of GCase, modeling studies indicated that ABX interacts with both active and non-active site residues. Thus, ABX has the biochemical characteristics of a safe and effective enzyme enhancement therapy agent for the treatment of patients with the most common GD genotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Signal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,296
Python: a programming language for software integration and development.
Sanner, M. F. (1999) · PubMed · Cited by 3,093
Enzymes: a practical introduction to structure, mechanism, and data analysis
(2001) · Choice Reviews Online · doi:10.5860/choice.38-3881 · Cited by 1,056
Zhang, Z., & Smith, D. L. (1993) · Protein Science · doi:10.1002/pro.5560020404 · Cited by 1,012
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Hruska, K. S., LaMarca, M. E., Scott, C. R., & Sidransky, E. (2008) · Human Mutation · doi:10.1002/humu.20676 · Cited by 678
Sawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Parkinsonism among Gaucher disease carriers
Goker-Alpan, O., Schiffmann, R., LaMarca, M. E., Nussbaum, R. L., McInerney-Leo, A., & Sidransky, E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024455 · Cited by 366
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Gan-Or, Z., Giladi, N., Rozovski, U., Shifrin, C., Rosner, S., Gurevich, T., Bar-Shira, A., & Orr-Urtreger, A. (2008) · Neurology · doi:10.1212/01.wnl.0000304039.11891.29 · Cited by 360
Analysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher Disease
Koprivica, V., Stone, D. L., Park, J. K., Callahan, M., Frisch, A., Cohen, I. J., Tayebi, N., & Sidransky, E. (2000) · The American Journal of Human Genetics · doi:10.1086/302925 · Cited by 334
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
Ron, I., & Horowitz, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi240 · Cited by 330
Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease
Lieberman, R. L., Wustman, B. A., Huertas, P., Powe, A. C., Pine, C. W., Khanna, R., Schlossmacher, M. G., Ringe, D., & Petsko, G. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio850 · Cited by 245
Cox, T. M., Aerts, J. M. F. G., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., Vom Dahl, S., Elstein, D., Erikson, A., et al. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1025902113005 · Cited by 236
Steet, R. A., Chung, S., Wustman, B., Powe, A., Do, H., & Kornfeld, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605928103 · Cited by 218
Wei, H., Kim, S.-J., Zhang, Z., Tsai, P.-C., Wisniewski, K. E., & Mukherjee, A. B. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm324 · Cited by 209
Ambroxol in the 21st century: pharmacological and clinical update
Malerba, M., & Ragnoli, B. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.8.1119 · Cited by 200
Beck, M. (2007) · Human Genetics · doi:10.1007/s00439-006-0280-4 · Cited by 199
The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations
Goker-Alpan, O., Lopez, G., Vithayathil, J., Davis, J., Hallett, M., & Sidransky, E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1353 · Cited by 199
Tropak, M. B., Reid, S. P., Guiral, M., Withers, S. G., & Mahuran, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308523200 · Cited by 197
Self-citationGeneration of Specific Deoxynojirimycin-type Inhibitors of the Non-lysosomal Glucosylceramidase
Overkleeft, H. S., Renkema, G. H., Neele, J., Vianello, P., Hung, I. O., Strijland, A., van der Burg, A. M., Koomen, G.-J., Pandit, U. K., & Aerts, J. M. F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26522 · Cited by 186
Fully Automated Molecular Mechanics Based Induced Fit Protein−Ligand Docking Method
Koska, J., Spassov, V. Z., Maynard, A. J., Yan, L., Austin, N., Flook, P. K., & Venkatachalam, C. M. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800081s · Cited by 171
Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis
Maegawa, G. H. B., Tropak, M., Buttner, J., Stockley, T., Kok, F., Clarke, J. T. R., & Mahuran, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609304200 · Cited by 171
Self-citationAn Adaptable Standard for Protein Export from the Endoplasmic Reticulum
Wiseman, R. L., Powers, E. T., Buxbaum, J. N., Kelly, J. W., & Balch, W. E. (2007) · Cell · doi:10.1016/j.cell.2007.10.025 · Cited by 155
Porto, C., Cardone, M., Fontana, F., Rossi, B., Tuzzi, M. R., Tarallo, A., Barone, M. V., Andria, G., & Parenti, G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.53 · Cited by 153
Yu, Z., Sawkar, A. R., Whalen, L. J., Wong, C., & Kelly, J. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060677i · Cited by 144
Rapid analysis of protein structure and dynamics by hydrogen/deuterium exchange mass spectrometry.
Hamuro, Y., Coales, S. J., Southern, M. R., Nemeth‐Cawley, J. F., Stranz, D. D., & Griffin, P. R. (2003) · PubMed Central · Cited by 138
Self-citationCox, T. M., Aerts, J. M. F. G., Belmatoug, N., Cappellini, M. D., Dahl, S. V., Goldblatt, J., Grabowski, G. A., Hollak, C. E. M., Hwu, W., Maas, M. M., et al. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0779-z · Cited by 137
Zheng, W., Padia, J. K., Urban, D. J., Jadhav, A., Göker-Alpan, Ö., Simeonov, A. M., Goldin, E., Auld, D. S., LaMarca, M. E., Inglese, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705637104 · Cited by 137
Chang, H., Asano, N., Ishii, S., Ichikawa, Y., & Fan, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05410.x · Cited by 133
Lin, H., Sugimoto, Y., Ohsaki, Y., Ninomiya, H., Oka, A., Taniguchi, M., Ida, H., Eto, Y., Ogawa, S., Matsuzaki, Y., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.03.007 · Cited by 125
Divergent phenotypes in Gaucher disease implicate the role of modifiers
Göker-Alpan, Ö., Hruska, K. S., Orvisky, E., Kishnani, P. S., Stubblefield, B. K., Schiffmann, R., & Sidransky, E. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028019 · Cited by 124
Gaucher disease: perspectives on a prototype lysosomal disease
Zhao, H., & Grabowski, G. A. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8458-y · Cited by 121
X-ray Structure of Human Acid-β-Glucosidase Covalently Bound to Conduritol-B-Epoxide
Premkumar, L., Sawkar, A. R., Boldin‐Adamsky, S., Toker, L., Silman, I., Kelly, J. W., Futerman, A. H., & Sussman, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502799200 · Cited by 118
Groener, J. E. M., Poorthuis, B. J. H. M., Kuiper, S., Helmond, M. T. J., Hollak, C. E. M., & Aerts, J. M. F. G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.079012 · Cited by 116
Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease
Schmitz, M., Alfalah, M., Aerts, J. M. F. G., Naim, H. Y., & Zimmer, K. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.008 · Cited by 107
Pharmacologic chaperoning as a strategy to treat Gaucher disease
Yu, Z., Sawkar, A. R., & Kelly, J. W. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06042.x · Cited by 105
Tropak, M. B., Blanchard, J. E., Withers, S. G., Brown, E. D., & Mahuran, D. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.12.006 · Cited by 105
Self-citationBiosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts
JONSSON, L. M. V., Murray, G. J., Sorrell, S. H., Strijland, A., Aerts, J. M. F. G., Ginns, E. I., Barranger, J. A., Tager, J. M., & Schram, A. W. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb11008.x · Cited by 94
Isofagomine Induced Stabilization of Glucocerebrosidase
Kornhaber, G. J., Tropak, M. B., Maegawa, G. H. B., Tuske, S. J., Coales, S. J., Mahuran, D. J., & Hamuro, Y. (2008) · ChemBioChem · doi:10.1002/cbic.200800249 · Cited by 90
Self-citationDiettrich, O., Mills, K. A., Johnson, A., Hasilík, A., & WINCHESTER, B. G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01578-6 · Cited by 83
Tropak, M. B., Kornhaber, G. J., Rigat, B. A., Maegawa, G. H. B., Buttner, J. D., Blanchard, J., Murphy, C., Tuske, S. J., Coales, S. J., Hamuro, Y., et al. (2008) · ChemBioChem · doi:10.1002/cbic.200800304 · Cited by 81
Self-citationTropak, M. B., & Mahuran, D. J. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06040.x · Cited by 77
Self-citationSecondary sphingolipid accumulation in a macrophage model of Gaucher disease
Hein, L. K., Meikle, P. J., Hopwood, J. J., et al. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.08.001 · Cited by 65
Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
Shen, J.-S., Edwards, N. J., Hong, Y. B., & Murray, G. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.125 · Cited by 59
Nortriptyline delays disease onset in models of chronic neurodegeneration
Wang, H., Guan, Y., Wang, X., Smith, K., Cormier, K., Zhu, S., Stavrovskaya, I. G., Huo, C., Ferrante, R. J., Kristal, B. S., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05663.x · Cited by 57
Brown, C. A., & Mahuran, D. J. (1993) · Europe PMC (PubMed Central) · Cited by 57
Self-citationBoston-Howes, W., Williams, E. O., Bogush, A. I., Scolere, M., Pasinelli, P., & Trotti, D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.010 · Cited by 52
Weiser, T. W. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2007.00032.x · Cited by 51
Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
Masuda, N., Peng, Q., Li, Q., Jiang, M., Liang, Y., Wang, X., Zhao, M., Wang, W., Ross, C. A., & Duan, W. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.014 · Cited by 51
Lü, Y., & FANG, J. (2003) · WORLD SCIENTIFIC eBooks · doi:10.1142/4854 · Cited by 51
Rigat, B. A., & Mahuran, D. J. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.12.008 · Cited by 46
Self-citationFuller, M., Rozaklis, T., Lovejoy, M., et al. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.11.011 · Cited by 43
Self-citationMolecular consequences of the pathogenic mutation in feline GM1 gangliosidosis
Martin, D. R., Rigat, B. A., Foureman, P. A., Varadarajan, G. S., Hwang, M., Krum, B. K., Smith, B. F., Callahan, J. W., Mahuran, D. J., & Baker, H. J. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.02.004 · Cited by 41
Self-citationTreatment perspectives for the lysosomal storage diseases
Grabowski, G. A. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.197 · Cited by 40
MAXIMUM LIKELIHOOD ESTIMATION FROM INCOMPLETE DATA VIA EM-TYPE ALGORITHMS
Liu, C. (2003) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812388759_0028 · Cited by 23
Gaucher disease: improving management
Bembi, B., & Deegan, P. B. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00643.x · Cited by 4
Cited by
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020441 · Cited by 868
Mullin, S., Smith, L., Lee, K., D’Souza, G., Woodgate, P., Elflein, J., Hällqvist, J., Toffoli, M., Streeter, A., Hosking, J., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4611 · Cited by 356
McNeill, A., Magalhaes, J., Shen, C., Chau, K.-Y., Hughes, D., Mehta, A., Foltynie, T., Cooper, J. M., Abramov, A. Y., Gegg, M., et al. (2014) · Brain · doi:10.1093/brain/awu020 · Cited by 321
Glucocerebrosidase and its relevance to Parkinson disease
Do, J., McKinney, C., Sharma, P., & Sidransky, E. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0336-2 · Cited by 300
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Smith, L., & Schapira, A. H. V. (2022) · Cells · doi:10.3390/cells11081261 · Cited by 256
Metadata
- Authors
- Maegawa, G. H. B., Tropak, M. B., Buttner, J. D., Rigat, B. A., Fuller, M., Pandit, D., Tang, L., Kornhaber, G. J., Hamuro, Y., Clarke, J. T. R., & Mahuran, D. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 284
- Issue
- 35
- Pages
- 23502-23516
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1979395048
- Cited by
- 332
- References
- 56
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.